Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostate Cancer Recurrent 1Ototoxicity 1Mucositis 1Glioblastoma 1Dermatitis 1Anus Neoplasms 1

Interventions

sodium thiosulfate 4Cisplatin 3Acetylcysteine 2tempol 1ebselen 1Vorinostat 1Thioctic Acid 1Sodium Chloride 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Pantoprazole 1Methotrexate 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Hyaluronic Acid 1Hearing Tests 1Dexamethasone 1Chemotherapy, Adjuvant 1Audiometry 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ototoxicity × tempol × Clear all
NCT03480971 2024-11-20

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Matrix Biomed, Inc.

Phase 2 Recruiting
120 enrolled
Other

Ototoxicity, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡